ScholarLens Back to search
1980•British journal of surgeryRequires access

Peritoneovenous shunting for ascites in cancer patients

J Oosterlee

Open publisher page 51 citations

Abstract

Twenty patients with malignant ascites were treated by insertion of a peritoneovenous shunt. Twelve had a LeVeen shunt, 7 a Denver shunt and 1 patient had a LeVeen shunt subsequently replaced by a Denver shunt. Overall survival was poor, which reflects the advanced stage of the patients' disease. Function of the Denver shunt seemed to be better than that of the LeVeen shunt. None of the 8 Denver shunts inserted was a complete failure, while 4 out of 13 LeVeen shunts were of no benefit. With a satisfactorily functioning shunt, good palliation was always achieved. A Denver shunt has become our first choice.

About this research paper

What this paper is about

Twenty patients with malignant ascites were treated by insertion of a peritoneovenous shunt. Twelve had a LeVeen shunt, 7 a Denver shunt and 1 patient had a LeVeen shunt subsequently replaced by a Denver shunt. Overall survival was poor, which reflects the advanced stage of the patients' disease. Function of the Denver shunt seemed to be better than that of the LeVeen shunt. None of the 8 Denver shunts inserted was a complete failure, while 4 out of 13 LeVeen shunts were of no benefit. With a satisfactorily functioning shunt, good palliation was always achieved. A Denver shunt has become our first choice.

Why it matters

OpenAlex reports 51 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Twenty patients with malignant ascites were treated by insertion of a peritoneovenous shunt. Twelve had a LeVeen shunt, 7 a Denver shunt and 1 patient had a LeVeen shunt subsequently replaced by a Denver shunt. Overall survival was poor, which reflects the advanced stage of the patients' disease. Function of the Denver shunt seemed to be better than that of the LeVeen shunt. None of the 8 Denver shunts inserted was a complete failure, while 4 out of 13 LeVeen shunts were of no benefit. With a satisfactorily functioning shunt, good palliation was always achieved. A Denver shunt has become our first choice.

Key concepts: Medicine, Peritoneovenous shunt, Ascites, Shunting, Cancer, Surgery, General surgery, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Peritoneovenous shunting for ascites in cancer patients — Research Paper | ScholarLens